{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T06:44:41Z","timestamp":1759041881191,"version":"3.40.4"},"reference-count":97,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,31]],"date-time":"2016-12-31T00:00:00Z","timestamp":1483142400000},"content-version":"vor","delay-in-days":791,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurolog\u00eda"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.nrl.2012.05.004","type":"journal-article","created":{"date-parts":[[2012,10,10]],"date-time":"2012-10-10T16:08:20Z","timestamp":1349885300000},"page":"523-532","source":"Crossref","is-referenced-by-count":10,"title":["Prescripciones inconvenientes en el tratamiento del paciente con deterioro cognitivo"],"prefix":"10.1016","volume":"29","author":[{"given":"A.","family":"Robles Bay\u00f3n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Gude Sampedro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nrl.2012.05.004_bib0005","unstructured":"Sanz \u00c1lvarez EJ, De las Cuevas Castresana C, Garc\u00eda del Pozo J. Ministerio de sanidad y pol\u00edtica social. Agencia espa\u00f1ola de medicamentos y productos sanitarios. Uso de benzodiacepinas en Espa\u00f1a (1992-2006). [consultado 3 may 2012]. Disponible en: http:\/\/www.aemps.gob.es\/medicamentosUsoHumano\/observatorio\/docs\/ansioliticos_hipnoticos.pdf"},{"key":"10.1016\/j.nrl.2012.05.004_bib0010","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2165\/00023210-200418010-00004","article-title":"Cognitive effects of long-term benzodiazepine use: a meta-analysis","volume":"18","author":"Barker","year":"2004","journal-title":"CNS Drugs"},{"key":"10.1016\/j.nrl.2012.05.004_bib0015","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0893-133X(02)00310-X","article-title":"Effects of alprazolam on driving ability, memory functioning and psychomotor performance: A randomized, placebo-controlled study","volume":"27","author":"Verster","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nrl.2012.05.004_bib0020","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1532-5415.2000.tb04729.x","article-title":"Benzodiazepines and the risk of falls in nursing home residents","volume":"48","author":"Ray","year":"2000","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.nrl.2012.05.004_bib0025","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1001\/archinternmed.2009.357","article-title":"Meta-analysis of the impact of 9 medication classes on falls in elderly persons","volume":"169","author":"Woolcott","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.nrl.2012.05.004_bib0030","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2165\/00002512-200825010-00007","article-title":"Benzodiazepines and injurious falls in community dwelling elders","volume":"25","author":"Pariente","year":"2008","journal-title":"Drugs Aging"},{"key":"10.1016\/j.nrl.2012.05.004_bib0035","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/hup.736","article-title":"Alcohol and\/or benzodiazepine use: different accidents--different impacts","volume":"20","author":"Kurzthaler","year":"2005","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.nrl.2012.05.004_bib0040","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.encep.2007.05.005","article-title":"R\u00e9actions d\u2019agressivit\u00e9 sous benzodiazepines: une revue de la litterature","volume":"34","author":"Sa\u00efas","year":"2008","journal-title":"Encephale"},{"key":"10.1016\/j.nrl.2012.05.004_bib0045","doi-asserted-by":"crossref","first-page":"23","DOI":"10.7202\/008615ar","article-title":"Benzodiaz\u00e9pines: cons\u00e9quences sur le fonctionnement mn\u00e9sique des personnes \u00e2g\u00e9es","volume":"28","author":"Quevillon","year":"2003","journal-title":"Sante Ment Que"},{"key":"10.1016\/j.nrl.2012.05.004_bib0050","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/ageing\/afq140","article-title":"Which medications to avoid in people at risk of delirium: a systematic review","volume":"40","author":"Clegg","year":"2011","journal-title":"Age Ageing"},{"key":"10.1016\/j.nrl.2012.05.004_bib0055","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1136\/bmj.38623.768588.47","article-title":"Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits","volume":"331","author":"Glass","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.nrl.2012.05.004_bib0060","doi-asserted-by":"crossref","first-page":"e000850","DOI":"10.1136\/bmjopen-2012-000850","article-title":"Hypnotics\u2019 association with mortality or cancer: a matched cohort study","volume":"2","author":"Kripke","year":"2012","journal-title":"BMJ Open"},{"key":"10.1016\/j.nrl.2012.05.004_bib0065","first-page":"w13277","article-title":"Is there a way to curb benzodiazepine addiction?","volume":"141","author":"Lalive","year":"2011","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.nrl.2012.05.004_bib0070","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1192\/bjp.bp.107.037788","article-title":"Efficacy and safety of pregabalin in elderly people with generalised anxiety disorder","volume":"193","author":"Montgomery","year":"2008","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.nrl.2012.05.004_bib0075","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1017\/S1461145709990460","article-title":"Comparative efficacy of pregabalin and benzodiazepines in treating the psychic and somatic symptoms of generalized anxiety disorder","volume":"13","author":"Lydiard","year":"2010","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.nrl.2012.05.004_bib0080","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1001\/jama.2008.977","article-title":"Escitalopram for older adults with generalized anxiety disorder: a randomized controlled trial","volume":"301","author":"Lenze","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.nrl.2012.05.004_bib0085","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.1532-5415.2002.50003.x","article-title":"Venlafaxine ER as a treatment for generalized anxiety disorder in older adults: pooled analysis of five randomized placebo-controlled clinical trials","volume":"50","author":"Katz","year":"2002","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.nrl.2012.05.004_bib0090","first-page":"153","article-title":"Duloxetine in the treatment of generalized anxiety disorder","volume":"2","author":"Wright","year":"2009","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.nrl.2012.05.004_bib0095","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1590\/S0004-282X2011000100010","article-title":"Trazodone for the treatment of sleep disorders in dementia. An open-label, observational and review study","volume":"69","author":"Camargos","year":"2011","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.nrl.2012.05.004_bib0100","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1159\/000077171","article-title":"Frontotemporal dementia: a randomised, controlled trial with trazodone","volume":"17","author":"Lebert","year":"2004","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.nrl.2012.05.004_bib0105","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1177\/0269881105056527","article-title":"Mirtazapine treatment of generalized anxiety disorder: a fixed dose, open label study","volume":"19","author":"Gambi","year":"2005","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.nrl.2012.05.004_bib0110","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/gps.2454","article-title":"Effectiveness of melatonin treatment on circadian rhythm disturbances in dementia. Are there implications for delirium? A systematic review","volume":"25","author":"de Jonghe","year":"2010","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.nrl.2012.05.004_bib0115","first-page":"39","article-title":"Quetiapine for the treatment of behavioural and psychological symptoms of dementia (BPSD): a meta-analysis of randomised placebo-controlled trials","volume":"124","author":"Cheung","year":"2011","journal-title":"N Z Med J"},{"key":"10.1016\/j.nrl.2012.05.004_bib0120","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1176\/appi.ajp.2011.11030347","article-title":"Risk of mortality among individual antipsychotics in patients with dementia","volume":"169","author":"Kales","year":"2012","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.nrl.2012.05.004_bib0125","doi-asserted-by":"crossref","first-page":"937","DOI":"10.2165\/00002512-200623120-00002","article-title":"Adverse effects of atypical antipsychotics in the elderly: a review","volume":"23","author":"Gareri","year":"2006","journal-title":"Drugs Aging"},{"key":"10.1016\/j.nrl.2012.05.004_bib0130","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S1130-6343(09)72168-3","article-title":"Mortalidad en pacientes con demencia tratados con antipsic\u00f3ticos at\u00edpicos (olanzapina, quetiapina y ziprasidona)","volume":"33","author":"Mart\u00ednez Mart\u00ednez","year":"2009","journal-title":"Farm Hosp"},{"key":"10.1016\/j.nrl.2012.05.004_bib0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.janxdis.2011.08.010","article-title":"Interventions for generalized anxiety disorder in older adults: Systematic review and meta-analysis","volume":"26","author":"Gon\u00e7alves","year":"2012","journal-title":"J Anxiety Disord"},{"key":"10.1016\/j.nrl.2012.05.004_bib0140","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1161\/HYPERTENSIONAHA.109.128744","article-title":"Change in blood pressure and incident dementia: a 32-year prospective study","volume":"54","author":"Stewart","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.nrl.2012.05.004_bib0145","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1161\/HYPERTENSIONAHA.109.147389","article-title":"Lowering mid-life levels of systolic blood pressure as a public health strategy to reduce late-life dementia: Perspective from the Honolulu Heart Program\/Honolulu Asia Aging Study","volume":"55","author":"Launer","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.nrl.2012.05.004_bib0150","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.regg.2010.12.005","article-title":"\u00bfCu\u00e1ndo y hasta cu\u00e1nto debemos bajar la presi\u00f3n arterial sist\u00f3lica en los ancianos? El debate contin\u00faa","volume":"46","author":"Castilla Guerra","year":"2011","journal-title":"Rev Esp Geriatr Gerontol"},{"key":"10.1016\/j.nrl.2012.05.004_bib0155","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1159\/000289821","article-title":"Low blood pressure is associated with cognitive impairment in very old people","volume":"29","author":"Molander","year":"2010","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.nrl.2012.05.004_bib0160","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/MBP.0b013e32830d4be6","article-title":"Low ambulatory blood pressure is associated with lower cognitive function in healthy elderly men","volume":"13","author":"Axelsson","year":"2008","journal-title":"Blood Press Monit"},{"key":"10.1016\/j.nrl.2012.05.004_bib0165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF03325209","article-title":"Low systolic blood pressure is associated with impaired cognitive function in the oldest old: longitudinal observations in a population-based sample 80 years and older","volume":"19","author":"Nilsson","year":"2007","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.nrl.2012.05.004_bib0170","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nrcardio.2010.161","article-title":"The relationship between blood pressure and cognitive function","volume":"7","author":"Novak","year":"2010","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.nrl.2012.05.004_bib0175","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1155\/2010\/725353","article-title":"Association between hypotension, low ejection fraction and cognitive performance in cardiac patients","volume":"22","author":"Gottesman","year":"2010","journal-title":"Behav Neurol"},{"key":"10.1016\/j.nrl.2012.05.004_bib0180","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.jacc.2011.01.008","volume":"57","author":"Aronow","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nrl.2012.05.004_bib0185","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/ije\/dyg106","article-title":"Cholesterol, coronary heart disease, and stroke in the Asia Pacific region","volume":"32","author":"Zhang","year":"2003","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.nrl.2012.05.004_bib0190","article-title":"Statins for the primary prevention of cardiovascular disease","volume":"1","author":"Taylor","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nrl.2012.05.004_bib0195","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0828-282X(06)70310-5","article-title":"Canadian Cardiovascular Society. Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease","volume":"22","author":"McPherson","year":"2006","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.nrl.2012.05.004_bib0200","first-page":"80","article-title":"Hipocolesterolemia: riesgo de mortalidad y su papel en la depresi\u00f3n, el deterioro cognoscitivo, el suicidio y la disminuci\u00f3n de la funcionalidad","volume":"6","author":"Garc\u00eda Mayo","year":"2003","journal-title":"Nutr Clin"},{"key":"10.1016\/j.nrl.2012.05.004_bib0205","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.atherosclerosis.2006.08.022","article-title":"Serum total cholesterol levels and risk of mortality from stroke and coronary heart disease in Japanese: the JACC study","volume":"194","author":"Cui","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.nrl.2012.05.004_bib0210","doi-asserted-by":"crossref","first-page":"261","DOI":"10.33588\/rn.4805.2008509","article-title":"Relaci\u00f3n entre los niveles circulatorios de colesterol y los trastornos neuropsiqui\u00e1tricos","volume":"48","author":"Mart\u00ednez-Carpio","year":"2009","journal-title":"Rev Neurol"},{"key":"10.1016\/j.nrl.2012.05.004_bib0215","doi-asserted-by":"crossref","first-page":"879","DOI":"10.5551\/jat.4176","article-title":"Association between lowering low-density lipoprotein cholesterol with pravastatin and primary prevention of cardiovascular disease in mild to moderate hypercholesterolemic Japanese","volume":"17","author":"Teramoto","year":"2010","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.nrl.2012.05.004_bib0220","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1161\/ATVBAHA.108.163998","article-title":"Low HDL cholesterol is a risk factor for deficit and decline in memory in midlife: the Whitehall II study","volume":"28","author":"Singh-Manoux","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.nrl.2012.05.004_bib0225","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.2337\/dc08-1677","article-title":"Low HDL cholesterol is associated with the risk of stroke in elderly diabetic individuals: changes in the risk for atherosclerotic diseases at various ages","volume":"32","author":"Hayashi","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.nrl.2012.05.004_bib0230","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/archinte.163.13.1549","article-title":"High-density vs low-density lipoprotein cholesterol as the risk factor for coronary artery disease and stroke in old age","volume":"163","author":"Weverling-Rijnsburger","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.nrl.2012.05.004_bib0235","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejpain.2006.01.001","article-title":"Pain in older adults: a prevalence study in the Mediterranean region of Catalonia","volume":"11","author":"Mir\u00f3","year":"2007","journal-title":"Eur J Pain"},{"key":"10.1016\/j.nrl.2012.05.004_bib0240","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2165\/11536530-000000000-00000","article-title":"Management of chronic arthritis pain in the elderly","volume":"27","author":"Fitzcharles","year":"2010","journal-title":"Drugs Aging"},{"issue":"Suppl. 3","key":"10.1016\/j.nrl.2012.05.004_bib0245","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.4065\/mcp.2009.0645","article-title":"Treatment considerations for patients with neuropathic pain and other medical comorbidities","volume":"85","author":"Haanp\u00e4\u00e4","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.nrl.2012.05.004_bib0250","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/gerona\/61.2.165","article-title":"Long-term effects of analgesics in a population of elderly nursing home residents with persistent nonmalignant pain","volume":"61","author":"Won","year":"2006","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.nrl.2012.05.004_bib0255","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios Utilizaci\u00f3n de opioides en Espa\u00f1a (1992-2006). [consultado 3 may 2012]. Disponible en: http:\/\/www.aemps.gob.es\/medicamentosUsoHumano\/observatorio\/docs\/opioides.pdf"},{"key":"10.1016\/j.nrl.2012.05.004_bib0260","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1533-2500.2008.00204.x","volume":"8","author":"Pergolizzi","year":"2008","journal-title":"Pain Pract"},{"key":"10.1016\/j.nrl.2012.05.004_bib0265","article-title":"Delirium: Screening, prevention, and diagnosis","author":"Greer","year":"2011","journal-title":"A systematic review of the evidence"},{"key":"10.1016\/j.nrl.2012.05.004_bib0270","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1001\/archinternmed.2010.391","article-title":"The comparative safety of analgesics in older adults with arthritis","volume":"170","author":"Solomon","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.nrl.2012.05.004_bib0275","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3122\/jabfm.2008.02.070144","article-title":"Quality of life associated with daily opioid therapy in a primary care chronic pain sample","volume":"21","author":"Dillie","year":"2008","journal-title":"J Am Board Fam Med"},{"key":"10.1016\/j.nrl.2012.05.004_bib0280","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1076\/neur.7.5.357.16245","article-title":"Hippocampal amnesia","volume":"7","author":"Spiers","year":"2001","journal-title":"Neurocase"},{"key":"10.1016\/j.nrl.2012.05.004_bib0285","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000332036","article-title":"Diffusion-weighted imaging for the differential diagnosis of disorders affecting the hippocampus","volume":"33","author":"F\u00f6rster","year":"2012","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.nrl.2012.05.004_bib0290","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1177\/0961203310392425","article-title":"Memory impairment associated with neurometabolic abnormalities of the hippocampus in patients with non-neuropsychiatric systemic lupus erythematosus","volume":"20","author":"Kozora","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.nrl.2012.05.004_bib0295","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1210\/jc.2008-2702","article-title":"Evidence for a specific defect in hippocampal memory in overt and subclinical hypothyroidism","volume":"94","author":"Correia","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.nrl.2012.05.004_bib0300","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1212\/01.wnl.0000200959.50898.26","article-title":"Hippocampal sclerosis in Alzheimer and other dementias","volume":"66","author":"Attems","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2012.05.004_bib0305","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.neurobiolaging.2005.03.021","article-title":"Age effects on atrophy rates of entorhinal cortex and hippocampus","volume":"27","author":"Du","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.nrl.2012.05.004_bib0310","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.mehy.2005.11.041","article-title":"Stress-induced change of mitochondria membrane potential regulated by genomic and non-genomic GR signaling: a possible mechanism for hippocampus atrophy in PTSD","volume":"66","author":"Zhang","year":"2006","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.nrl.2012.05.004_bib0315","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1001\/archpsyc.57.10.925","article-title":"Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders","volume":"57","author":"Sapolsky","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.nrl.2012.05.004_bib0320","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1093\/brain\/awh617","article-title":"Vestibular loss causes hippocampal atrophy and impaired spatial memory in humans","volume":"128","author":"Brandt","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.nrl.2012.05.004_bib0325","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1212\/WNL.0b013e318230a16c","article-title":"Chronic divalproex sodium use and brain atrophy in Alzheimer disease","volume":"77","author":"Fleisher","year":"2011","journal-title":"Neurology"},{"issue":"Suppl. 1","key":"10.1016\/j.nrl.2012.05.004_bib0330","first-page":"S29","article-title":"Amnesia del desarrollo como secuela cognitiva focal de patolog\u00eda neonatal","volume":"52","author":"Sans","year":"2011","journal-title":"Rev Neurol"},{"key":"10.1016\/j.nrl.2012.05.004_bib0335","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.neurol.2011.01.007","article-title":"Amn\u00e9sie pure progressive isol\u00e9e pendant 16ans et atrophie focalis\u00e9e de l\u2019hippocampe","volume":"167","author":"Richard-Mornas","year":"2011","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.nrl.2012.05.004_bib0340","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1212\/WNL.58.11.1635","article-title":"Effects of subcortical ischemic vascular dementia and AD on entorhinal cortex and hippocampus","volume":"58","author":"Du","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2012.05.004_bib0345","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1371\/journal.pmed.0040338","article-title":"Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials","volume":"4","author":"Raschetti","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.nrl.2012.05.004_bib0350","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1532-5415.2011.03450.x","article-title":"Dementia medications and risk of falls, syncope, and related adverse events: Meta-analysis of randomized controlled trials","volume":"59","author":"Kim","year":"2011","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.nrl.2012.05.004_bib0355","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1161\/STROKEAHA.109.570077","article-title":"Randomized, placebo-controlled, clinical trial of donepezil in vascular dementia: differential effects by hippocampal size","volume":"41","author":"Rom\u00e1n","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2012.05.004_bib0360","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1212\/01.wnl.0000266625.31615.f6","article-title":"Galantamine treatment of vascular dementia: a randomized trial","volume":"69","author":"Auchus","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2012.05.004_bib0365","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1185\/03007990802328142","article-title":"Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the VantagE study","volume":"24","author":"Ballard","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.nrl.2012.05.004_bib0370","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1177\/0269881110387547","article-title":"Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology","volume":"25","author":"O\u2019Brien","year":"2011","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.nrl.2012.05.004_bib0375","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1586\/ern.10.105","article-title":"Cholinesterase inhibitors: beyond Alzheimer's disease","volume":"10","author":"Larner","year":"2010","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.nrl.2012.05.004_bib0380","first-page":"27","article-title":"Relative tolerability of Alzheimer's disease treatments","volume":"5","author":"Alva","year":"2008","journal-title":"Psychiatry (Edgemont)"},{"key":"10.1016\/j.nrl.2012.05.004_bib0385","first-page":"95","article-title":"Bradycardia due to cholinesterase inhibitors: identify adverse effects and take them into account","volume":"20","author":"An\u00f3nimo","year":"2011","journal-title":"Prescrire Int"},{"key":"10.1016\/j.nrl.2012.05.004_bib0390","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2165\/11530300-000000000-00000","article-title":"Factors associated with serious adverse reactions to cholinesterase inhibitors: a study of spontaneous reporting","volume":"24","author":"Pariente","year":"2010","journal-title":"CNS Drugs"},{"key":"10.1016\/j.nrl.2012.05.004_bib0395","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archneurol.2011.69","article-title":"Lack of evidence for the efficacy of memantine in mild Alzheimer disease","volume":"68","author":"Schneider","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nrl.2012.05.004_bib0400","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S1474-4422(10)70194-0","article-title":"Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial","volume":"9","author":"Emre","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nrl.2012.05.004_bib0405","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S1474-4422(09)70146-2","article-title":"Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial","volume":"8","author":"Aarsland","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nrl.2012.05.004_bib0410","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1161\/01.STR.0000020094.08790.49","article-title":"Efficacy and safety of memantine in patients with mild to moderate vascular dementia. A randomized, placebo-controlled trial (MM300)","volume":"33","author":"Orgogozo","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2012.05.004_bib0415","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00004850-200211000-00005","article-title":"A double-blind placebo-controlled multicentre study of memantine in mild to moderate vascular dementia. (MM500)","volume":"17","author":"Wilcock","year":"2002","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.nrl.2012.05.004_bib0420","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.parkreldis.2006.08.005","article-title":"A pilot study of the clinical efficacy and safety of memantine for Huntington's disease","volume":"13","author":"Ondo","year":"2007","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.nrl.2012.05.004_bib0425","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1097\/QAD.0b013e32813384e8","article-title":"Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study","volume":"21","author":"Schifitto","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.nrl.2012.05.004_bib0430","doi-asserted-by":"crossref","first-page":"456","DOI":"10.3109\/17482968.2010.498521","article-title":"A randomized, placebo-controlled trial of memantine for functional disability in amyotrophic lateral sclerosis","volume":"11","author":"de Carvalho","year":"2010","journal-title":"Amyotroph Lateral Scler"},{"key":"10.1016\/j.nrl.2012.05.004_bib0435","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.pnpbp.2008.01.008","article-title":"A systematic review of off-label uses of memantine for psychiatric disorders","volume":"32","author":"Zdanys","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.nrl.2012.05.004_bib0440","first-page":"45","article-title":"Anticholinergic and sedative medicines. Prescribing considerations for people with dementia","volume":"41","author":"Bell","year":"2012","journal-title":"Aust Fam Physician"},{"key":"10.1016\/j.nrl.2012.05.004_bib0445","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.clinthera.2005.02.014","article-title":"Central nervous system safety of anticholinergic drugs for the treatment of overactive bladder in the elderly","volume":"27","author":"Scheife","year":"2005","journal-title":"Clin Ther"},{"key":"10.1016\/j.nrl.2012.05.004_bib0450","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMc061003","article-title":"Delirium in older persons","volume":"354","author":"Anton","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nrl.2012.05.004_bib0455","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/mds.10276","article-title":"Sublingual atropine for sialorrhea secondary to parkinsonism: a pilot study","volume":"17","author":"Hyson","year":"2002","journal-title":"Mov Disord"},{"key":"10.1016\/j.nrl.2012.05.004_bib0460","article-title":"The use of anticholinergics for the management of terminal secretions","volume":"1","author":"Gray","year":"2007","journal-title":"Evidence Matters"},{"key":"10.1016\/j.nrl.2012.05.004_bib0465","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.archger.2008.07.011","article-title":"Mental confusion associated with scopolamine patch in elderly with mild cognitive impairment (MCI)","volume":"49","author":"Seo","year":"2009","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.nrl.2012.05.004_bib0470","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000322883","article-title":"Anticholinergic drugs and their effects on delirium and mortality in the elderly","volume":"1","author":"Luukkanen","year":"2011","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"10.1016\/j.nrl.2012.05.004_bib0475","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1196\/annals.1314.018","article-title":"The steroid dementia syndrome: an unrecognized complication of glucocorticoid treatment","volume":"1032","author":"Wolkowitz","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.nrl.2012.05.004_bib0480","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1212\/01.wnl.0000229924.76258.c1","article-title":"Reversible dementia with parkinsonian features associated with budesonide use","volume":"67","author":"Prodan","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2012.05.004_bib0485","first-page":"1071","article-title":"Revisiting the O complex: urinary incontinence, delirium and polypharmacy in elderly patients","volume":"157","author":"Hogan","year":"1997","journal-title":"CMAJ"}],"container-title":["Neurolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485312001855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485312001855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T10:33:48Z","timestamp":1744281228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213485312001855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":97,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0213485312001855"],"URL":"https:\/\/doi.org\/10.1016\/j.nrl.2012.05.004","relation":{},"ISSN":["0213-4853"],"issn-type":[{"type":"print","value":"0213-4853"}],"subject":[],"published":{"date-parts":[[2014,11]]}}}